×← Back to all dealsOverview
- FOR SALE BY OWNER. OWNED BY ENTREPRENEURS WHO HAVE CLOSED MULTIPLE M&A TRANSACTIONS. THE OWNER/ADMINISTRATOR NEEDS TO RELOCATE DUE TO GROWING FAMILY NEEDS. OTHERWISE, IT WON'T BE AVAILABLE FOR SALE AND WILL CONTINUE ITS GROWTH TRAJECTORY. COMPREHENSIVE CIM AND MONTHLY FINANCIAL MODEL AVAILABLE UPON EXECUTION OF THE NDA. - VALUATION INDICATION: $1.00M – $1.18M indicated value 4.25x – 5.0x applied to Dec 2026F SDE of $235,411 ($1,000,495 – $1,177,053). On TTM May 2026 SDE of $182,796 the same multiples indicate $776,882 – $913,978. Seven private home health transactions in BVR DealStats trade at 3.70x – 4.50x MVIC/SDE, the two Medicare-certified comparables highest at 4.09x and 4.50x. ULTIMATELY, THE MARKETPLACE, DEMAND, AND COMPETITION WILL DETERMINE SALE PRICE. The Company is a Medicare-certified home health agency founded multiple decades ago and continuously Medicare-enrolled, operating in Minnesota. 33 employees serve a current census of 134 patients under a comprehensive Minnesota home health care license, an active NPI, and seven payor contracts. The S-Corp owner acts solely as a non-clinical administrator. Clinical operations sit with a tenured, non-owner Director of Nursing who is committed post-close. SERVICES: Skilled nursing — RN wound care, medication management, disease monitoring and patient education. Home health aides — bathing and dressing, meal preparation and light housekeeping. Homemaking and companionship — household support and companion care for lower-acuity clients. KEY INVESTMENT HIGHLIGHTS: Federally frozen entry. On May 13, 2026 CMS imposed a nationwide moratorium on all new Medicare home health enrollments - no new agencies, branches or practice locations anywhere in the United States, no exceptions and no waivers, extendable in six-month increments. A Medicare certification can no longer be built, it can only be bought. Certification multi-decades past the 36-month rule. Enrollment dates back multi-decades ago with no change in majority ownership in the last 36 months, so the acquisition is exempt from re-enrollment under 42 CFR §424.550(b) - whereas a recently certified agency changing hands during the freeze would lose enrollment with no path back. Growth in both volume and rate. Revenue rose from $580,436 in FY2023 to $1,267,731 forecast for FY2026 - a ~30% CAGR - as average census grew 89 to 147 (+65%) and revenue per visit climbed from $83 to $122. No single-payor dependency. Seven active payors - Medicare, Medicaid (MN DHS), Blue Cross MN, Medica, UCare(now Medica), VA, HealthPartners and UnitedHealthcare. Turnkey, non-clinical ownership. Because the owner is an administrator rather than a clinician, the acquirer buys an intact clinical organization: the Director of Nursing, referral relationships, and platform continue unchanged, and the owner remains available for transition support. Expansion frozen for everyone. The moratorium also blocks incumbents from adding branches, so white space across the current footprint cannot be contested while it holds. GROWTH LEVERS: Therapy adjacencies — Medicare PT, OT, and speech-therapy lines add revenue per patient. Fixed SG&A leverage — a path to 22%+ SDE margins as revenue scales past $1.3M. Bolt-ons and VA growth — licensed Minnesota agencies are now scarce exit targets, and VA visits already run 156 per month (TTM).